Merit Medical Systems Inc (MMSI)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $5.19B
Last updated: Nov 17, 2026 at 11:06 AM ET
Merit Medical Systems Inc (MMSI) Earnings: Report Dates and Results
Merit Medical Systems (MMSI) is expected to report earnings on Feb 22, 2027. In the quarter ended Sep 30, 2026, Merit Medical Systems reported EPS of $1.01, above the $0.93 estimate. It beat the EPS estimate in each of the last 28 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
MMSI has an expected report date of Feb 22, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 8.7% above the $1.04 reported for the quarter ended Dec 31, 2025.
MMSI Earnings Call
The latest MMSI earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 40 quarters below that had an estimate, MMSI beat 38 and missed 2. Revenue for the quarter ended Sep 30, 2026 was $416.24M, up 8.4% from $384.16M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $1.01 | $0.93 | N/A | +8.60% | Beat | +9.8% | 11 | 6 up, 1 down | Oct 29, 2026 | $416.24M |
| Jun 30, 2026 | $1.09 | $0.85 | N/A | +28.24% | Beat | +7.9% | 9 | 0 up, 1 down | Jul 30, 2026 | $418.84M |
| Mar 31, 2026 | $0.94 | $0.83 | $0.81 - $0.85 | +13.25% | Beat | +9.3% | 10 | 0 up, 8 down | Apr 30, 2026 | $381.88M |
| Dec 31, 2025 | $1.04 | $0.95 | $0.93 - $0.98 | +9.50% | Beat | +11.8% | 10 | 1 up, 0 down | Feb 24, 2026 | $393.94M |
| Sep 30, 2025 | $0.92 | $0.83 | $0.80 - $0.86 | +10.84% | Beat | +7.0% | 10 | 8 up, 1 down | Oct 30, 2025 | $384.16M |
| Jun 30, 2025 | $1.01 | $0.85 | $0.83 - $0.88 | +18.82% | Beat | +9.8% | 10 | 1 up, 0 down | Jul 30, 2025 | $382.46M |
| Mar 31, 2025 | $0.86 | $0.75 | $0.74 - $0.76 | +14.67% | Beat | +11.7% | 10 | 0 up, 6 down | Apr 24, 2025 | $355.35M |
| Dec 31, 2024 | $0.93 | $0.83 | $0.81 - $0.85 | +12.05% | Beat | +14.8% | 9 | 3 up, 0 down | Feb 25, 2025 | $355.16M |
| Sep 30, 2024 | $0.86 | $0.80 | $0.79 - $0.81 | +7.50% | Beat | +14.7% | 10 | 0 up, 0 down | Oct 30, 2024 | $339.85M |
| Jun 30, 2024 | $0.92 | $0.87 | $0.84 - $0.89 | +5.75% | Beat | +13.6% | 10 | 0 up, 0 down | Aug 1, 2024 | $338.00M |
| Mar 31, 2024 | $0.77 | $0.72 | $0.71 - $0.72 | +6.94% | Beat | +20.3% | 9 | 0 up, 0 down | Apr 30, 2024 | $323.51M |
| Dec 31, 2023 | $0.81 | $0.77 | $0.75 - $0.79 | +5.19% | Beat | +2.5% | 8 | 0 up, 0 down | Feb 28, 2024 | $324.51M |
| Sep 30, 2023 | $0.75 | $0.65 | $0.64 - $0.66 | +15.38% | Beat | +17.2% | 7 | 0 up, 0 down | Oct 26, 2023 | $315.23M |
| Jun 30, 2023 | $0.81 | $0.76 | $0.74 - $0.78 | +6.58% | Beat | +11.0% | 7 | 0 up, 0 down | Jul 25, 2023 | $320.06M |
| Mar 31, 2023 | $0.64 | $0.55 | $0.53 - $0.56 | +16.36% | Beat | +20.8% | 7 | 0 up, 0 down | Apr 26, 2023 | $297.56M |
| Dec 31, 2022 | $0.79 | $0.67 | $0.65 - $0.69 | +17.91% | Beat | +11.3% | 7 | 0 up, 0 down | Feb 22, 2023 | $293.42M |
| Sep 30, 2022 | $0.64 | $0.53 | $0.51 - $0.55 | +20.75% | Beat | +23.1% | 7 | 0 up, 0 down | Oct 26, 2022 | $287.18M |
| Jun 30, 2022 | $0.73 | $0.58 | $0.55 - $0.60 | +25.86% | Beat | +17.7% | 7 | 0 up, 0 down | Jul 27, 2022 | $294.98M |
| Mar 31, 2022 | $0.53 | $0.47 | $0.45 - $0.48 | +12.77% | Beat | +1.9% | 7 | 0 up, 0 down | Apr 27, 2022 | $275.42M |
| Dec 31, 2021 | $0.71 | $0.52 | $0.49 - $0.54 | +36.54% | Beat | +31.5% | 7 | 0 up, 0 down | Feb 24, 2022 | $278.49M |
| Sep 30, 2021 | $0.52 | $0.44 | $0.39 - $0.49 | +18.18% | Beat | +23.8% | 8 | N/A | Oct 28, 2021 | $267.02M |
| Jun 30, 2021 | $0.62 | $0.45 | $0.42 - $0.46 | +37.78% | Beat | +100.0% | 8 | N/A | Jul 29, 2021 | $280.32M |
| Mar 31, 2021 | $0.52 | $0.36 | $0.33 - $0.41 | +44.44% | Beat | +36.8% | 8 | N/A | Apr 29, 2021 | $248.91M |
| Dec 31, 2020 | $0.54 | $0.43 | $0.38 - $0.46 | +25.58% | Beat | +35.0% | 8 | N/A | Feb 24, 2021 | $258.00M |
| Sep 30, 2020 | $0.42 | $0.20 | $0.13 - $0.24 | +110.00% | Beat | +50.0% | 8 | N/A | Oct 28, 2020 | $243.97M |
| Jun 30, 2020 | $0.31 | $0.07 | -$0.09 - $0.17 | +342.86% | Beat | -26.2% | 8 | N/A | Jul 29, 2020 | $218.37M |
| Mar 31, 2020 | $0.38 | $0.26 | $0.20 - $0.35 | +46.15% | Beat | +2.7% | 8 | N/A | Apr 23, 2020 | $243.53M |
| Dec 31, 2019 | $0.40 | $0.34 | $0.33 - $0.37 | +17.65% | Beat | -16.7% | 8 | N/A | Feb 24, 2020 | $257.92M |
| Sep 30, 2019 | $0.28 | $0.45 | $0.43 - $0.47 | -37.78% | Miss | -40.4% | 8 | N/A | Oct 30, 2019 | $243.05M |
| Jun 30, 2019 | $0.42 | $0.50 | $0.47 - $0.51 | -16.00% | Miss | -2.3% | 6 | N/A | Jul 25, 2019 | $255.53M |
| Mar 31, 2019 | $0.37 | $0.36 | $0.35 - $0.37 | +2.78% | Beat | +19.4% | 8 | N/A | Apr 23, 2019 | $238.35M |
| Dec 31, 2018 | $0.48 | $0.45 | $0.42 - $0.48 | +6.67% | Beat | +45.5% | 8 | N/A | Feb 26, 2019 | $233.25M |
| Sep 30, 2018 | $0.47 | $0.42 | $0.41 - $0.43 | +11.90% | Beat | +46.9% | 8 | N/A | Oct 25, 2018 | $221.66M |
| Jun 30, 2018 | $0.43 | $0.40 | $0.37 - $0.42 | +7.50% | Beat | +19.4% | 8 | N/A | Jul 23, 2018 | $224.81M |
| Mar 31, 2018 | $0.31 | $0.29 | $0.23 - $0.33 | +6.90% | Beat | +10.7% | 8 | N/A | Apr 25, 2018 | $203.03M |
| Dec 31, 2017 | $0.33 | $0.32 | $0.30 - $0.33 | +3.13% | Beat | +6.5% | 7 | N/A | Feb 28, 2018 | $190.90M |
| Sep 30, 2017 | $0.32 | $0.30 | $0.28 - $0.31 | +6.67% | Beat | +23.1% | 8 | N/A | Oct 25, 2017 | $179.34M |
| Jun 30, 2017 | $0.36 | $0.29 | $0.28 - $0.31 | +24.14% | Beat | +38.5% | 8 | N/A | Jul 26, 2017 | $186.55M |
| Mar 31, 2017 | $0.28 | $0.23 | N/A | +21.74% | Beat | +47.4% | N/A | N/A | Apr 27, 2017 | $171.07M |
| Dec 31, 2016 | $0.31 | $0.28 | N/A | +10.71% | Beat | +29.2% | N/A | N/A | Feb 21, 2017 | $157.72M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $3.83, up 10.1% from the year before. It was $1.02 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $3.83 | +10.1% |
| Dec 31, 2024 | $3.48 | +15.6% |
| Dec 31, 2023 | $3.01 | +11.9% |
| Dec 31, 2022 | $2.69 | +13.5% |
| Dec 31, 2021 | $2.37 | +43.6% |
| Dec 31, 2020 | $1.65 | +12.2% |
| Dec 31, 2019 | $1.47 | -13.0% |
| Dec 31, 2018 | $1.69 | +31.0% |
| Dec 31, 2017 | $1.29 | +26.5% |
| Dec 31, 2016 | $1.02 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 9,000 words across 15 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 9,003 | 15 | |
| 2026Q2 | Jun 30, 2026 | 7,861 | 14 | |
| 2026Q1 | Mar 31, 2026 | 6,949 | 13 | |
| 2025Q4 | Dec 31, 2025 | 8,266 | 11 | |
| 2025Q3 | Sep 30, 2025 | 10,044 | 12 | |
| 2025Q2 | Jun 30, 2025 | 8,754 | 13 | |
| 2025Q1 | Mar 31, 2025 | 9,317 | 14 | |
| 2024Q4 | Dec 31, 2024 | 6,737 | 13 |
2026Q3 Earnings Call
Opening remarks
Martha Aronson President and Chief Executive Officer Thank you, operator, and welcome, everyone. I am joined on the call today by Raul Parra, our Chief Financial Officer and Treasurer; and Brian Lloyd, our Chief Legal Officer and Corporate Secretary. Brian, would you please take us through the safe harbor statements?
Brian Lloyd Chief Legal Officer and Corporate Secretary Thank you, Martha. This presentation contains forward-looking statements that receive safe harbor protection under federal securities laws. Our actual results may differ materially from the expectations and projections expressed or implied by our forward-looking statements. Please refer to the sections entitled "Cautionary Statement" regarding forward-looking statements in today's press release and presentation for important information regarding such statements. In addition, any forward-looking statements represent our views only as of today, October 29, 2026, and should not be relied upon as representing our views as of any other date. We specifically disclaim any obligation to update such statements, except as required by applicable law. This presentation also contains certain non-GAAP financial measures. A reconciliation of non-GAAP financial measures to the most directly comparable U.S. GAAP measures is included in today's press release and presentation furnished to the SEC under Form 8-K. Please refer to the sections of our press release and presentation entitled "Non-GAAP Financial Measures" for important information regarding non-GAAP financial measures discussed on this call. Both today's press release and our presentation are available on the Investors page of our website. I will now turn the call back to Martha.
Martha Aronson President and Chief Executive Officer Thank you, Brian. Let me start with a brief agenda of what we will cover during our prepared remarks. I will begin with a brief summary of the third quarter financial results; then I will provide several operational updates and progress areas in Q3; Raul will then provide a more in-depth review of the quarterly financial results, as well as our financial guidance for 2026, which we updated in today's press release; then we will open the call for your questions. Beginning with a review of our third quarter results. For avoidance of doubt, all growth figures are on a constant currency basis, unless otherwise noted. We reported total revenue of $416 million, up 8% year-over-year on both a GAAP and constant currency basis. Our total revenue results exceeded the high end of the expectations that we outlined on our Q2 earnings call. Third quarter total constant currency growth was driven by 9% organic growth, which also exceeded the high end of our expectations, and follows the 9% organic growth we delivered in Q2. By way of reminder, our organic growth excludes the contributions from acquisitions in the current year period and revenue from divested products in the prior year period. We saw strong growth trends in the U.S.
Frequently Asked Questions About MMSI
When is Merit Medical Systems's next earnings date?
Merit Medical Systems's next earnings report is expected for Feb 22, 2027.
Did MMSI beat earnings estimates last quarter?
Yes. Merit Medical Systems reported EPS of $1.01 for the quarter ended Sep 30, 2026, above the $0.93 estimate, a 8.60% surprise.
What EPS do analysts expect from MMSI next quarter?
The consensus EPS estimate for Merit Medical Systems for the quarter ending Dec 31, 2026 is $1.13 from 14 analysts, with estimates from $1.07 to $1.19.
How often does MMSI beat earnings estimates?
Merit Medical Systems beat the EPS estimate in each of the last 28 quarters, with an average surprise of +33.43%.
MMSI pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts